Exclusive: ACR Convergence 2024 | Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Conditions
FocusRheum
Guidance
Drug Updates
- Analgesics
- Biologics/DMARDs
Practice Support
- Billing/Coding
- EMRs
- Facility
- Insurance
- QA/QI
- Technology
- Workforce
Opinion
Career
ACR
Search

No Clear Connection Between Inflammation & Disease Progression in AS

Kathy Holliman | Issue: October 2010 | October 1, 2010

Page: 1 2 3 4 | Single Page

Share:

Filed under:Axial Spondyloarthritis Conditions Other Rheumatic Conditions Rheumatoid Arthritis Tagged with:Ankylosing Spondylitis inflammation RA Rheumatoid arthritis therapy tumor necrosis factor

Related Articles

Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

May 8, 2012

Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

“A Common Language for Spondyloarthritis”

December 1, 2010

ASAS fills a niche, changes dogma with consensus approach

Imaging in Ankylosing Spondylitis

April 1, 2015

MRI inflammation, fat and new bone formation in the sacroiliac joints, spine in patients with AS

Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

May 1, 2014

New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

About Us
Meet the Editors
Issue Archives
Contribute
Advertise
Contact Us

Copyright © 2000-2024 American College of Rheumatology. All rights reserved. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
DEI Statement
Privacy Policy
Terms of Use
Cookie Preferences